相关实验视频
Updated: Jun 28, 2025

06:50
Extraction and Analysis of Taiwanese Green Propolis
Published on: January 7, 2019
8.5K
来自土耳其Siirt的的抗氧化剂,抗糖尿病作用和多醇含量
Eda Ören1, Salih Tuncay1, Yunus Emre Toprak1
1Department of Food Technology, Vocational School of Health Services Uskudar University Istanbul Turkey.
Food science & nutrition
|April 17, 2024
概括
富含化合物的Siirt提取物具有显著的抗氧化和抗糖尿病特性. 这种天然产品显示出治疗糖尿病和相关代谢障碍的潜力.
科学领域:
- 自然产品 化学 化学
- 药理学 药理学 是一个学科.
- 生物化学 生物化学
背景情况:
- 蜂是一种来自蜜蜂的产品,含有具有治疗潜力的生物活性化合物.
- 氧化应激和代谢障碍,如糖尿病,是严重的健康问题.
- 了解的成分和活性对于其药物应用至关重要.
研究的目的:
- 分析Siirt提取物中的化合物.
- 评估这些提取物的抗氧化和抗糖尿病活性.
- 探索在治疗糖尿病中的潜力.
主要方法:
- 用乙醇,水和乙醇-水混合物制备了 прополис提取物.
- 使用液体染色学-质谱学/质谱学 (LC-MS/MS) 进行了烯基分析.
- 通过DPPH和ABTS测定来评估抗氧化活性;通过抑制α-氨酶和α-糖酶酶来评估抗糖尿病活性.
主要成果:
- прополис 提取物具有中度的激素清除潜力 (13.86%-35.72% DPPH, 33.62%-62.50% ABTS 在 30 μg/mL).
- 高含量与显著的α-葡萄糖酶抑制相关 (IC50 = 5.72 ± 0.83 μg/mL).
- 以乙醇为基础的提取物显示出更高的活性,表明溶剂依赖的疗效.
结论:
- 西尔特具有显著的抗氧化和抗糖尿病特性.
- 它的化合物有助于其生物活性,特别是抑制α-葡萄糖酶.
- 是一种有前途的天然治疗剂,用于糖尿病和代谢障碍.
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
174
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
174
Oral Hypoglycemic Agents: Biguanides and Glitazones
195
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
195
Oral Hypoglycemic Agents: Sulfonylureas
207
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
207

